ReviewAnnals of translational medicine2020
Statistics of heart failure and mechanical circulatory support in 2020.
Review in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Low-fat hypocaloric diet reduces neprilysin in overweight and obese human subjects.ESC heart failure · 2021Trial
- A novel approach for predicting heart failure survival using a rectangular coded network.Physical and engineering sciences in medicine · 2026Article
- Translation, cultural adaptation, and validation of the amharic version of the Minnesota Living with Heart Failure Questionnaire (MLHFQ).Journal of patient-reported outcomes · 2026Article
- Effectiveness of symptom perception interventions among patients with heart failure: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2026Review
- Worsening versus advanced heart failure: Management and challenges.ESC heart failure · 2025Review
- Application of Molecular Hydrogen in Early Heart Failure Development: Modulation of Microcirculation, Metabolism, Oxidative Stress, and Myocardial Status.Antioxidants (Basel, Switzerland) · 2025Article
- Sex-Specific Disparities in the Female Vs Male Patient Population in Left Ventricular Assist Device Use.CJC open · 2025Review
- Reconstructing 12-lead ECG from reduced lead sets using an encoder-decoder convolutional neural network.Biomedical signal processing and control · 2025Article
- Predicting right ventricular failure after left ventricular assist device implant: A novel approach.ESC heart failure · 2025Article
- Anticoagulation with Nafamostat Mesilate During Impella Support: A Case Report.Medicina (Kaunas, Lithuania) · 2025Article
- On the development of diagnostic support algorithms based on CPET biosignals dataPeerJ. Computer science · 2025Article
- Weaning in early neurological-neurosurgical rehabilitation in Germany - results from a nationwide online survey.Frontiers in neurology · 2025Article
- Article
- Synchronous PIV measurements of a self-powered blood turbine and pump couple for right ventricle support.Scientific reports · 2024Article
- Applications of 3D Printing Technology in Diagnosis and Management of Heart Failure.Current treatment options in cardiovascular medicine · 2024Article
- Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction.Current treatment options in cardiovascular medicine · 2024Article
- Practical Comparison of Two- and Three-Phase Bearingless Permanent Magnet Slice Motors for Blood Pumps.Actuators · 2024Article
- Article
- Disparities by Sex, Race, and Ethnicity in Use of Left Ventricular Assist Devices and Heart Transplants Among Patients With Heart Failure With Reduced Ejection Fraction.Journal of the American Heart Association · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure is increasing in prevalence, with approximately 26 million patients affected worldwide. This represents a significant cause of morbidity and mortality. Statistics regarding heart failure patient age, hospitalization likelihood, and mortality differ significantly by country. Heart failure patients are typically classified by ejection fraction, with distinct phenotypes associated with reduced ejection fraction (rEF) or preserved ejection fraction (pEF). Heart failure has a significant financial impact related to hospitalization, medication, and procedural expenses. The costs of heart failure also extend to the reduced quality of life conferred by heart failure symptoms. Management of heart failure includes a variety of interventions, including mechanical circulatory support (MCS). MCS, including left ventricular assist devices (LVADs), right ventricular assist devices (RVADs) and extracorporeal membrane oxygenation (ECMO), has been a means of managing end stage heart failure. Given the relative scarcity of transplant organs, the utilization of MCS, particularly as a bridge to transplantation (BTT) has grown significantly. In this review, we discuss statistics related to heart failure and MCS. We evaluate how patients are classified and examine global trends and regional differences. We then address MCS therapies, the costs associated with heart failure, the impact of heart failure on patient quality of life, and data regarding morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.